High AXL expression in breast cancer is associated with reduced survival [51], and suppression of AXL prevented the initiation of ovarian metastases in mice [47]; AXL gene expression was moderate to high in 4 of the 7 NCI-60 ovarian cancer lines (Figure 6B). This evidence concerns the gene AXL and ovarian carcinoma.